Ana Maria Ortega-Prieto
Overview
Explore the profile of Ana Maria Ortega-Prieto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ortega-Prieto A, Regla-Nava J, Jimenez-Guardeno J
Front Microbiol
. 2024 Oct;
15:1496035.
PMID: 39464402
No abstract available.
2.
Ortega-Prieto A, Jimenez-Guardeno J
mBio
. 2024 Aug;
15(9):e0210024.
PMID: 39171921
The coronavirus disease 2019 (COVID-19) pandemic remains an international health problem caused by the recent emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of May 2024, SARS-CoV-2...
3.
Reis de Andrade J, Scourfield E, Peswani-Sajnani S, Poulton K, Ap Rees T, Khooshemehri P, et al.
Biol Methods Protoc
. 2024 Jul;
9(1):bpae046.
PMID: 38993523
Rapid and accessible testing was paramount in the management of the COVID-19 pandemic. Our university established KCL TEST: a SARS-CoV-2 asymptomatic testing programme that enabled sensitive and accessible PCR testing...
4.
Martinez-Fernandez D, Fernandez-Quezada D, Casillas-Munoz F, Carrillo-Ballesteros F, Ortega-Prieto A, Jimenez-Guardeno J, et al.
Pathogens
. 2023 Jul;
12(7).
PMID: 37513794
Monkeypox virus (MPXV) is an emerging zoonotic virus that belongs to the Orthopoxvirus genus and presents clinical symptoms similar to those of smallpox, such as fever and vesicular-pustular skin lesions....
5.
Burnap S, Ortega-Prieto A, Jimenez-Guardeno J, Ali H, Takov K, Fish M, et al.
Mol Cell Proteomics
. 2023 Jun;
22(8):100600.
PMID: 37343697
High-density lipoprotein (HDL) levels are reduced in patients with coronavirus disease 2019 (COVID-19), and the extent of this reduction is associated with poor clinical outcomes. While lipoproteins are known to...
6.
Jimenez-Guardeno J, Ortega-Prieto A, Menendez Moreno B, Maguire T, Richardson A, Diaz-Hernandez J, et al.
PLoS Comput Biol
. 2022 Jul;
18(7):e1010330.
PMID: 35849631
The COVID-19 pandemic has accelerated the need to identify new antiviral therapeutics at pace, including through drug repurposing. We employed a Quadratic Unbounded Binary Optimization (QUBO) model, to search for...
7.
Sabariegos R, Ortega-Prieto A, Diaz-Martinez L, Grande-Perez A, Garcia Crespo C, Gallego I, et al.
PLoS Pathog
. 2022 Jan;
18(1):e1010210.
PMID: 35085375
In the course of experiments aimed at deciphering the inhibition mechanism of mycophenolic acid and ribavirin in hepatitis C virus (HCV) infection, we observed an inhibitory effect of the nucleoside...
8.
Pluripotent Stem Cell-Derived Hepatocytes Inhibit T Cell Proliferation through Tryptophan Starvation
Romano M, Elgueta R, McCluskey D, Ortega-Prieto A, Stolarczyk E, Dazzi F, et al.
Cells
. 2022 Jan;
11(1).
PMID: 35011586
Regenerative medicine aims to replace damaged tissues by stimulating endogenous tissue repair or by transplanting autologous or allogeneic cells. Due to their capacity to produce unlimited numbers of cells of...
9.
Dupont L, Snell L, Graham C, Seow J, Merrick B, Lechmere T, et al.
Nat Microbiol
. 2021 Oct;
6(11):1433-1442.
PMID: 34654917
COVID-19 vaccine design and vaccination rollout need to take into account a detailed understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and emerging variants of concern (VOCs). Analyses of...
10.
Pascual-Iglesias A, Canton J, Ortega-Prieto A, Jimenez-Guardeno J, Regla-Nava J
Pathogens
. 2021 Aug;
10(8).
PMID: 34451494
The emergence of SARS-CoV-2 in late 2019 led to the COVID-19 pandemic all over the world. When the virus was first isolated and its genome was sequenced in the early...